A Bioinformatics Analysis Of Circulating Microrna Signatures As Novel Biomarkers For Predicting Chemotherapy Response
Journal of Multidisciplinary Sustainability Asean · 20.06.2025 · 2 (3) · 158-171
DOI: 10.70177/ijmsa.v2i3.2663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Multidisciplinary Sustainability Asean, online erschienen am 20.06.2025. Verfasst von T. Amirul Muttaqin und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Chemotherapy response is highly variable, leading to ineffective treatment and toxicity. Reliable, non-invasive biomarkers to predict response a priori are urgently needed. Circulating microRNAs (miRNAs) are stable liquid biopsy candidates, but previous studies often lack robust validation.
Purpose
This study aimed to identify and validate a novel, non-invasive circulating miRNA signature to accurately predict chemotherapy response using a large-scale bioinformatic approach.
Method
A comprehensive in silico study was conducted. We aggregated and harmonized 948 patient samples from five public datasets (GEO, TCGA). A machine learning pipeline (LASSO + Random Forest) was applied to a Training Set (n=664) to discover a predictive signature. The signature was then validated in an Internal Testing Set (n=284) and a separate External Validation Cohort (n=120).
Results
We aggregated and harmonized 948 patient samples from five public datasets (GEO, TCGA). A machine learning pipeline (LASSO + Random Forest) was applied to a Training Set (n=664) to discover a predictive signature. The signature was then validated in an Internal Testing Set (n=284) and a separate External Validation Cohort (n=120). We identified and validated a 7-miRNA circulating signature (c-miRSig). The model demonstrated high accuracy in both the internal (AUC 0.89) and external (AUC 0.86) validation sets.
Conclusion
The signature was also a powerful prognostic tool, significantly stratifying patients for progression-free survival (p < 0.001). Functional analysis linked the signature to key chemoresistance pathways (PI3K-Akt, ABC transporters). The c-miRSig is a robust, non-invasive biomarker with dual predictive and prognostic power. This computationally validated signature provides a strong foundation for a clinically viable test to personalize chemotherapy, sparing non-responders from toxic, ineffective treatment.
Zitieren
APA
Muttaqin, T. A., Allen, E., & Salazar, B. (2025). A Bioinformatics Analysis Of Circulating Microrna Signatures As Novel Biomarkers For Predicting Chemotherapy Response. Journal of Multidisciplinary Sustainability Asean, 2(3), 158-171. https://doi.org/10.70177/ijmsa.v2i3.2663
Vancouver
Muttaqin TA, Allen E, Salazar B. A Bioinformatics Analysis Of Circulating Microrna Signatures As Novel Biomarkers For Predicting Chemotherapy Response. Journal of Multidisciplinary Sustainability Asean. 2025;2(3):158-171. doi:10.70177/ijmsa.v2i3.2663
BibTeX
@article{Muttaqin2025,
author = {Muttaqin, T. Amirul and Allen, Esther and Salazar, Beatriz},
title = {A Bioinformatics Analysis Of Circulating Microrna Signatures As Novel Biomarkers For Predicting Chemotherapy Response},
journal = {Journal of Multidisciplinary Sustainability Asean},
year = {2025},
volume = {2},
number = {3},
pages = {158--171},
doi = {10.70177/ijmsa.v2i3.2663}
}
EUVIMED